Industry Renews Push For EPA To Reconsider TCE's Birth Defects Risk

摘要

Industry is asking EPA to reconsider its rejection of a petition questioning the agency's use of a controversial study to conclude that the solvent trichloroethylene (TCE) causes cardiac birth defects, arguing the agency's refusal earlier this year to grant the request for correction under the Information Quality Act (IQA) relied on a flawed peer review. The Halogenated Solvents Industry Alliance, Inc. (HSIA) in a June 17 request for reconsideration of the group's November 2013 IQA petition reiterates industry's long-standing assertion that EPA should not have relied on a 2003 toxicology study by Paula D. Johnson showing a risk of cardiac birth defects in lab rodents exposed to TCE, which industry argues is flawed and unreproducible.